Kohei Yokoyama Selected Research

Enzymes

6/2005	Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
2/2003	Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kohei Yokoyama Research Topics

Disease

6	Malaria 01/2008 - 02/2003
3	African Trypanosomiasis (Nagana) 08/2005 - 08/2002
2	Parasitic Diseases (Parasitic Disease) 02/2006 - 02/2003
1	Hypoglycemia (Reactive Hypoglycemia) 01/2023
1	Ichthyosis (Xeroderma) 01/2017
1	Chagas Disease (American Trypanosomiasis) 01/2008
1	Infections 02/2003
1	Mycoses (Diseases, Fungus) 02/2003

Drug/Important Bio-Agent (IBA)

4	p21(ras) farnesyl-protein transferase (protein farnesyltransferase)IBA 01/2008 - 08/2002
3	Proteins (Proteins, Gene)FDA Link 01/2008 - 02/2003
2	Farnesyltranstransferase (Farnesyltransferase)IBA 09/2006 - 08/2005
2	TransferasesIBA 08/2005 - 02/2003
2	EnzymesIBA 06/2005 - 02/2003
1	Histones (Histone)IBA 01/2023
1	Methionine (L-Methionine)FDA Link 01/2023
1	Choline (Choline Chloride)IBA 01/2023
1	fibroblast growth factor 21IBA 01/2023
1	Phospholipases (Phospholipase)IBA 01/2017
1	Amino Acids FDA Link 01/2008

Therapy/Procedure

5	Therapeutics 09/2006 - 02/2003